Search results

Selected filters:

Strategy
Europe

Article type

Topic

Sector

Jurisdictions

312 results found for your search

Sort options
16 July 2019

Gilead’s unique $5.1 billion licensing deal shows the range of IP monetisation options open to biotech sector

New boss explains that the Big Pharma company will seek out “diverse and creative” asset partnerships – rather than large acquisitions – to boost its pipeline

10 July 2019

All the big life sciences IP developments in June

Our round-up of the major patent issues affecting pharma and biotech that emerged on the legal, market and policy fronts last month

03 July 2019

Law firm’s patent attorney deal shows changing face of IP practice in the UK

Lewis Silkin’s acquisition of Ablett & Stebbing is a first and demonstrates just how far things have moved in a once conservative market

02 July 2019

Japanese aircon giant latest to pledge patent non-aggression

Ten years ago, the company bet big on sharing technology with Chinese upstarts. Now Daikin is opening up a portfolio of refrigerant patents

02 July 2019

AbbVie’s Allergan play designed to mitigate Humira patent cliff

The $63 billion purchase is designed to mitigate the effects of losing the exclusive rights to the world’s best selling drug

27 June 2019

Huawei has reaped $1.4 billion in licence fees since 2015, white paper says

The Chinese company also revealed its royalty outflow – $6 billion since it took its first licence in 2001, 80% of which has gone to US companies

27 June 2019

Everything you wanted to know about AI patents, but were afraid to ask - part 2

After a WIPO report in April, new analysis from the UK IP Office sheds further light on this rapidly growing area and confirms that, despite a Chinese filing surge, the US continues to dominate

17 June 2019

Why it's time for the world of patents to embrace diversity and gender equality

Special IAM boardroom session at IPBC Global 2019 focuses on how to get more women involved in senior positions in the global IP market - and why everyone will win when it happens

13 June 2019

Huawei’s $1 billion Verizon demand: politics or profit?

Ongoing royalty negotiations are revealed after US network operator reportedly notifies government. Why the conflict, which follows a 2016 dispute with T-Mobile, may alarm Nokia and Ericsson

12 June 2019

IAM and sister publication GDR launch major data event

The Data Business Congress will take place in San Jose, CA, next February with the focus on the capture, protection, management, exploitation and monetisation of one of the pivotal assets of the 21st century

06 June 2019

Siemens asserting Chinese wireless patents against four local mobile firms

Following successful invalidation petitions lodged by Vivo against the German company, industry sources tell IAM that Oppo, Xiaomi and Meizu also face SEP assertions in specialised IP courts

03 June 2019

Deloitte makes major IP play with acquisition of top advisory

Big Four firm closes deal to acquire UK-based ClearView in a further sign that IP value creation is moving to the centre of the corporate agenda 

30 May 2019

AB InBev IP exec explains how he is helping to shift attitudes one six-pack at a time

With the giant brewer facing off against Heineken in court, Michael Swita sets out how innovation and patents are becoming a far bigger consideration in the industry

28 May 2019

US biotech aims to curb China’s genomics leader with pair of European lawsuits

Shenzhen BGI was once the biggest purchaser of Illumina’s gene sequencing machines. Now the two are on opposite sides of an expanding patent battle

24 May 2019

AI and machine-learning patentability: a strategic perspective

Recent guidance from the EPO and USPTO gives IP owners more clarity over what can be considered patentable in AI and machine learning.